(secondQuint)Dexmedetomidine Cardiovascular Safety in Pediatric Burn Patients.

 This is an ascending dose study evaluating the cardiovascular safety of dexmedetomidine bolus/infusions in acutely burned pediatric patients.

 The study entails a bolus of dexmedetomidine, followed by 2 hours of increasing infusion doses.

 Cardiovascular parameters including EKG, heart rate, oxygen saturation, blood pressure, are recorded.

.

 Dexmedetomidine Cardiovascular Safety in Pediatric Burn Patients@highlight

Dexmedetomidine is a sedative drug approved for adult patients, intubated, in intensive care units.

 We are studying whether this drug is cardiovascularly safe in pediatric patients who have recently been burned.

